SUMMARY

Professor Thomas Seyfried, a Boston College biology expert, discusses cancer as a mitochondrial metabolic disease driven by fermentation of glucose and glutamine, challenging genetic theories and advocating non-toxic metabolic therapies like ketogenic diets and targeted drugs for better outcomes.

STATEMENTS

Professor Thomas Seyfried is a biology professor at Boston College, teaching cancer metabolism and general biology to diverse students.
Seyfried's research focuses on developing non-toxic diet-drug therapies to manage all types of cancer without harming normal cells.
His team collaborates with global clinics to apply preclinical metabolic therapy knowledge to cancer patients, yielding astonishing success reports.
They refine strategies based on feedback, aiming to make metabolic therapy the standard for cancer care.
Cancer originates from mitochondrial damage, as validated by Otto Warburg's 1920s-1940s findings, forcing cells into fermentation for survival.
Electron micrographs of major cancers show structurally abnormal mitochondria, confirming impaired oxidative phosphorylation.
Cancer cells rely on fermenting glucose to lactic acid and glutamine, without which they cannot survive.
Genetic mutations, angiogenesis, and apoptosis failures are downstream effects of mitochondrial damage, not the cause.
The oncogenic paradox explains how diverse insults like infections, wounds, radiation, or inflammation damage mitochondria, leading to dysregulated cell growth.
Cancer mimics ancient fermentation pathways from before oxygen's atmospheric presence 2.5 billion years ago.
Standard treatments like radiation and chemotherapy often increase glucose and glutamine availability, worsening outcomes.
No advances in glioblastoma therapy have occurred in nearly 100 years, despite technological progress elsewhere.
Ketogenic diets enhance mitochondrial efficiency and number, protecting against cancer by limiting fermentable fuels.
Excessive carbohydrates cause chronic inflammation, contributing to cancer, type 2 diabetes, Alzheimer's, and cardiovascular disease.
Humans evolved for seasonal, not chronic, high-carbohydrate intake; modern diets mismatch our evolutionary biology.
Chronic diseases stem from nutritional imbalances and toxin buildup from inappropriate diets, not inherent genetic flaws.
Industrially produced vegetables with pesticides damage mitochondria via biofluorescence, initiating cancer in fermentable cells.
Cells unable to upregulate fermentation, like cardiomyocytes or neurons, rarely become tumorigenic.
Hospital cancer diets high in sugary carbs drive tumor growth, contradicting basic biology.
Radiation and temozolomide in glioblastoma treatment free up glucose and glutamine, sealing patients' fates.
Patients fear chemotherapy's toxicity as much as cancer itself; water-only fasting may mitigate some effects.
Metabolic therapy lacks a business model, stalling adoption despite proven efficacy in preclinical models.
6-Diazo-5-oxo-L-norleucine (DON), a glutamine-targeting drug, is unavailable for human use despite past applications and low toxicity.
Cancer treatment generates massive revenue through drugs, radiation, and insurance, prioritizing profit over patient survival.
Institutional review boards mandate standard care before metabolic therapy, delaying effective interventions.
Patient advocates, like glioblastoma survivor Pablo Kelly, demonstrate long-term survival via strict low-carb diets without standard treatments.
The Glucose Ketone Index (GKI) monitors nutritional ketosis via blood tests, correlating with tumor control.
Cancer cells cannot burn ketones or fats, only glucose and glutamine; diets alone limit glucose but not glutamine.
Combining ketogenic diets with DON could rapidly eliminate tumors by targeting both fuels.
All major cancers—lung, breast, colon, bladder, kidney, blood—are susceptible to metabolic therapy due to universal fermentation.
Naturally arising cancers in animal models respond well; genetically engineered models may not, but human relevance is low.
Cancer rates in domestic dogs have risen with processed pet foods; wild wolves rarely get cancer on natural diets.
Zoo animals on natural diets avoid chronic diseases; feeding them human junk food would be cruelty.
Big Food and Big Pharma form an alliance: processed carbs cause illness, then drugs treat symptoms, driving economies.
Prevention maintains healthy mitochondria; Warburg noted cancer cannot arise without mitochondrial damage.
Nuclear-cytoplasmic transfer experiments show tumor nuclei in healthy cytoplasm regain growth regulation, proving mutations are not causal.
Metabolic therapy manages, not necessarily cures, cancer, extending life with higher quality without toxicity.
Survivors of toxic treatments suffer lifelong issues like gastrointestinal, psychiatric, and hormonal problems.
Press-Pulse strategy uses diet as sustained pressure and pulsed drugs to degrade tumors while boosting normal cell health.
Metabolic therapy resolves comorbidities like diabetes and hypertension alongside cancer management.

IDEAS

Cancer's true origin lies in mitochondrial dysfunction, not genetics, flipping decades of research on its head.
Fermentation fuels glucose and glutamine power nearly all cancers, offering a universal therapeutic target overlooked by gene-focused science.
The oncogenic paradox reveals how unrelated insults converge on mitochondrial damage, unifying cancer's diverse triggers.
Ancient evolutionary biology explains cancer as a reversion to pre-oxygen fermentation, making modern treatments paradoxically counterproductive.
Standard cancer therapies inadvertently fuel tumor growth by liberating fermentable substrates, dooming patients to poor outcomes.
Ketogenic states not only starve cancer cells but enhance healthy mitochondrial biogenesis, turning metabolism into a protective shield.
Chronic carb overload inflames the body, birthing a cascade of diseases from cancer to dementia, all traceable to dietary mismatch.
Pesticides and plant toxins target mitochondria directly, explaining why only ferment-capable cells turn cancerous.
Hospitals feeding sugar to cancer patients is like pouring gasoline on a fire, highlighting a profound knowledge gap in oncology.
Profit motives block metabolic drugs like DON, despite their safety and efficacy, exposing healthcare's revenue-driven core.
Patient empowerment through GKI monitoring transforms passive victims into active controllers of their disease trajectory.
Therapeutic mutations like IDH1 act as natural drugs, doubling survival if unhindered by toxic standards of care.
All cancers ferment uniformly despite genetic chaos, suggesting metabolic targeting trumps futile mutation hunts.
Wild animals and zoo primates thrive cancer-free on natural diets, indicting human processed foods as the real carcinogen.
Big Food-Pharma symbiosis profits from sickness: carbs induce disease, drugs manage symptoms, perpetuating a vicious cycle.
Nuclear transfer experiments demolish genetic theory, showing mutated nuclei normalize with healthy mitochondria.
Metabolic therapy heals comorbidities, linking cancer to broader metabolic imbalances for holistic recovery.
Resistance to metabolic approaches stems from systemic inertia, not evidence, demanding patient-led advocacy for change.
Pediatric cancers respond dramatically to non-toxic strategies, averting developmental tragedies from radiation.
Future mitochondrial replacement could reverse cancer, but current tools already enable management without suffering.
Carnivore or strict keto diets halt tumor progression, as seen in survivors outliving predictions by years.
Globally uniform toxic standards ignore cultural openness, trapping even alternative medicine hubs in outdated paradigms.
Accountability for cancer fundraising is absent; proceeds fuel genetic research, not effective metabolic prevention.
Transitioning to zero-carb eases fasting, making metabolic shifts feasible even for carb-addicted brains.
Biopsies risk spreading cancer unnecessarily, prioritizing gene profiling over simple fuel deprivation.

INSIGHTS

Viewing cancer metabolically unifies its causes and treatments, rendering genetic obsessions a costly distraction from fermentation's core role.
Evolutionary mismatch in diets explains surging chronic diseases, positioning metabolic therapy as prevention's missing link.
Toxic standards liberate tumor fuels, turning interventions into accelerators that explain stagnant survival rates.
Patient self-monitoring via GKI fosters agency, motivating compliance and yielding outsized survival gains.
Profit barriers, not biology, stall safe drugs like DON, revealing healthcare's moral compromise on human lives.
Therapeutic mutations highlight nature's built-in therapies, undermined by interventions that sabotage innate advantages.
Uniform fermentation across heterogeneous tumors demands metabolic, not genetic, precision for universal efficacy.
Natural diets in wild and captive animals underscore processed carbs as the environmental cancer driver.
Press-Pulse dynamics degrade tumors while revitalizing hosts, addressing cancer's metabolic web holistically.
Systemic mandates prioritize revenue over evidence, necessitating grassroots patient advocacy for paradigm shift.
Mitochondrial transfer proves causality, abstracting cancer as a reversible organelle failure, not genomic destiny.
Global treatment lockstep ignores local successes, perpetuating tragedy through unexamined consensus.
Empowerment through knowledge converts despair to control, extending quality life beyond predictions.
Comorbidity resolution in metabolic therapy reveals cancer's roots in systemic nutritional toxicity.
Future mitochondrial therapies promise reversal, but current strategies already manage without the barbarity of chemo-radiation.

QUOTES

"Cancer originated from damage to mitochondria and that then elicited a whole series of changes forcing the cell into a fermentation mechanism to survive."
"We have never found normal mitochondria in any kind of a major cancer."
"Without the glucose and glutamine no cancer cell can survive."
"The definition of cancer is cell division out of control or dysregulated cell growth."
"The cancer cells in bodies are simply falling back on these ancient pathways that have always existed even before respiration even before the origination of the mitochondria."
"Some of the standards of care actually facilitate the availability of fermentable fuels making the management of the disease impossible."
"Excessive amounts of carbohydrates facilitate the inflammatory condition in the body and it's this elevated inflammation that contributes to the damage."
"We as a species did not evolve to eat large amounts of carbohydrates."
"Carcinogens are going right to the mitochondria and damaging the mitochondria which is then the first step in the initiation of cancer."
"The very treatments that are used free up massive amounts of glucose and glutamine in the tumor micro environment making long-term survival very very rare."
"There's no way yet that people have found out how to make money on metabolic therapy that's the biggest problem."
"Cancer is a revenue generating disease."
"You should do metabolic therapy first and then you'll be shocked at how you won't need toxic radiation and chemicals."
"The cancer cells can't burn ketones or fats they only can burn glucose and glutamine."
"Metabolic therapy can allow the patient to live longer it's a management strategy you can manage the disease."
"We can't torture human beings as well as what some of the standard of care does to people."
"All they have to do is pull the plug on the glucose and glutamine while under nutritional ketosis and you don't have to spend 265,000 to have your cancer managed."
"You can't get cancer if your mitochondria remain healthy."
"The future of cancer is bright not bleak."
"Educate people educate the practitioners and things will begin to change."

HABITS

Maintain strict zero-carbohydrate diets, such as carnivore or ketogenic, to limit glucose and induce nutritional ketosis.
Monitor blood glucose and ketone levels every other day using a meter like Keto-Mojo to track the Glucose Ketone Index (GKI).
Transition gradually to water-only fasting after 2-4 weeks on zero-carb to ease withdrawal from glucose addiction.
Incorporate organic, home-grown vegetables fertilized naturally if including plants, to minimize pesticide exposure.
Avoid all processed carbs, sugars, and alcohol to prevent inflammation and fuel availability for cancer cells.
Engage in regular physical activity, like gardening or walking, to sustain quality of life during therapy.
Collaborate with knowledgeable clinics for personalized diet-drug timing and dosing to optimize efficacy.
Prioritize whole, species-appropriate foods like fatty meats (e.g., tomahawk ribeye) for sustained energy without carbs.
Track tumor response via non-invasive imaging rather than biopsies to avoid risks and monitor progress.
Build compliance through education and motivation, viewing diet as a tool for personal control over disease.
Pulse low-dose, repurposed drugs like DON or mebendazole with diet for targeted metabolic disruption without chronic use.
Foster mental resilience by focusing on empowerment, measuring daily actions against survival goals.

FACTS

Cancer rates in the U.S. have tripled in the past 40 years, correlating with post-1977 dietary shifts to higher carbs and lower fats.
Otto Warburg's theory from the 1920s-1940s posited cancer as mitochondrial damage leading to fermentation, now validated by Seyfried's 150+ studies.
No normal mitochondria appear in electron micrographs of 95% of major cancers, from lung to breast.
Glutamine fermentation, alongside glucose, drives most cancers; it's the most abundant amino acid in the body.
Glioblastoma patients survive 3 months untreated, 15-18 months with standard care, with no advances in 100 years.
Radiation and temozolomide increase tumor glucose and glutamine, reducing long-term survival.
Ketogenic diets have treated refractory epilepsy since 1921, used daily by tens of thousands of children worldwide.
Domestic dog cancer rates surged with packaged pet foods; wild wolves rarely develop cancer.
Zoo primates on natural diets avoid human-like chronic diseases; junk food would constitute animal abuse.
China sees 8,100 daily cancer deaths, now the top killer surpassing heart disease.
U.S. cancer deaths accumulate yearly at population growth rates, with no treatment-driven reductions.
IDH1 mutations double glioblastoma survival by blocking glucose and glutamine pathways naturally.
Nuclear transfer experiments show tumor nuclei normalize growth in healthy cytoplasm with functional mitochondria.
Processed carbs contribute to $2.4 trillion in global metabolic disease treatment costs annually, versus $1.3 trillion sugar industry revenue.
Mebendazole costs 50 cents per tablet in India but $300 in the U.S. for cancer repurposing.
Over 1,600 Americans die daily from cancer, totaling millions yearly without accountability in fundraising.
Chimpanzees share 98% genetic similarity with humans and develop similar diseases on Western diets.
Metabolic therapy in mouse models extends metastatic survival 5-fold without toxicity.
Press-Pulse strategy resolves diabetes and hypertension alongside cancer in preclinical trials.

REFERENCES

Otto Warburg's works on cancer metabolism (1920s-1940s).
Seyfried's book: Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer (Wiley, 2012).
Seyfried's 150+ peer-reviewed studies in biology and cancer biology.
Electron micrograph studies from 1950s-1970s on cancer mitochondria.
Pablo Kelly's website and story (glioblastoma survivor, 8 years on carnivore diet).
Glucose Ketone Index (GKI) calculator for monitoring ketosis.
Keto-Mojo blood glucose-ketone meter.
New paper: "Clinical research framework proposal for ketogenic metabolic therapy in glioblastoma brain cancer" (BMC Medicine).
Video: "Prof. Thomas Seyfried - 'Cancer as a Metabolic Disease'".
Study: "Ketogenic diets and cancer treatment" (NCBI).
Study: "Fasting mimicking diet helps triple negative breast cancer" (PubMed).
Meta-analysis: "Cancer Treatment With the Ketogenic Diet: A Systematic Review and Meta-analysis of Animal Studies" (Frontiers).
Carnivore cancer treatment center in Hungary.
Video: "Dr. David Harper - 'Ketogenic Diets to Prevent and Treat Cancer'".
Video: "Thomas Seyfried, PhD -- Cancer as a Mitochondrial Metabolic Disease".
Study: "Keto and glutamine, GBM treatment Seyfried" (Nature).
Study: "Cancer causing polyunsaturated fat (Mitochondria effect)" (ScienceDirect).
Study: "Red meat doesn't increase risk of colon cancer or all cause mortality" (MDPI).
Film: First Do No Harm (1997, with Meryl Streep) on ketogenic diet for epilepsy.
Charlie Foundation for ketogenic therapies.
Wilder's 1921 Mayo Clinic work on ketogenic diets for epilepsy.
Press-Pulse therapeutic strategy paper with clinician colleagues.
Miriam Kalamian’s expertise and co-authored treatment protocol for keto in cancer.
Guy Townsend's story of overcoming stage four prostate cancer metabolically.
Foundation for Cancer Metabolic Therapies (for donations and support).
Boston College research program for Seyfried's work.

HOW TO APPLY

Educate yourself on cancer as a metabolic disease via Seyfried's book and papers to grasp the fermentation mechanism.
Compute your baseline GKI using a blood meter to assess current glucose-ketone balance before changes.
Gradually eliminate all carbohydrates over 2-4 weeks, starting with processed sugars and grains to minimize withdrawal.
Shift to high-fat, zero-carb meals like fatty meats and organic veggies to induce mild ketosis safely.
Test blood levels bi-daily, aiming for GKI under 2 for therapeutic ketosis in cancer management.
Transition to 3-5 days of water-only fasting once adapted, monitoring for energy stability.
Pulse low-dose glutamine inhibitors like DON if accessible, timing with peak ketosis for maximal tumor pressure.
Incorporate repurposed drugs such as mebendazole under guidance, scheduling around diet phases.
Use non-invasive imaging like MRI every 3 months to track tumor response without biopsy risks.
Maintain strict compliance by journaling meals and motivations, viewing diet as disease control.
Address comorbidities by integrating metabolic therapy, monitoring blood pressure and sugar improvements.
Collaborate with a metabolic-savvy clinic for personalized dosing and feedback loops.
Avoid standard care initially if possible, prioritizing metabolic approaches to prevent fuel liberation.
Rally support from patient networks like Pablo Kelly's for motivation and shared strategies.
Donate to metabolic research foundations to accelerate drug access and trials.
Transition pets to natural diets if applicable, observing reduced cancer risks in animals.
Advocate to policymakers for DON repurposing, citing preclinical efficacy and low toxicity.
Track progress with quality-of-life metrics, adjusting based on energy and vitality gains.
Prepare for long-term management, committing to zero-carb indefinitely post-remission.

ONE-SENTENCE TAKEAWAY

Embrace metabolic therapy to manage cancer as mitochondrial fermentation, starving tumors non-toxically for extended, quality survival.

RECOMMENDATIONS

Adopt a zero-carbohydrate ketogenic or carnivore diet immediately upon diagnosis to deprive tumors of glucose.
Monitor GKI daily with blood tests, targeting values below 2 for optimal therapeutic pressure.
Seek clinics offering metabolic protocols, avoiding major centers locked into standard care.
Transition gradually to fasting, starting with zero-carb to build tolerance before water-only phases.
Pressure legislators for access to glutamine-targeting drugs like DON, emphasizing their proven safety.
Prioritize metabolic therapy before any radiation or chemo to prevent counterproductive fuel release.
Educate family and advocates to support compliance, using survivor stories for motivation.
Incorporate organic, low-toxin foods to minimize mitochondrial damage from pesticides.
Use Press-Pulse: sustain diet pressure, pulse cheap repurposed drugs like mebendazole strategically.
Track imaging non-invasively to validate progress, avoiding biopsies that risk spread.
Address all chronic conditions simultaneously, as metabolic shifts resolve diabetes and hypertension too.
Rally patient communities online to demand systemic change and share real outcomes.
Fund metabolic research directly, bypassing genetic-focused institutions for faster impact.
For pediatrics, insist on non-toxic options to preserve cognitive development.
View cancer management as lifelong empowerment, not a quick fix, for sustained vitality.
Experiment with hyperbaric oxygen alongside keto to enhance drug delivery without toxicity.
Cut all alcohol and sweets permanently, recognizing them as direct tumor accelerators.
Prepare mentally by studying evolutionary biology, understanding carbs as modern mismatch.

MEMO

In a groundbreaking interview on the Plant-Free MD podcast, Professor Thomas Seyfried of Boston College dismantles the genetic dogma of cancer, asserting it as a metabolic disorder rooted in damaged mitochondria. Drawing from Otto Warburg's century-old insights, Seyfried explains how insults like radiation, inflammation, or pesticides impair oxidative phosphorylation, forcing cells into primitive fermentation of glucose and glutamine. This shift, he argues, drives dysregulated growth across all major cancers, from glioblastoma to lung, rendering them uniformly vulnerable to fuel deprivation. "We have never found normal mitochondria in any kind of a major cancer," Seyfried states, backed by decades of electron microscopy and his 150-plus studies.

Seyfried's research at Boston College pioneers non-toxic therapies, combining ketogenic diets with targeted drugs to starve tumors while bolstering healthy cells. His team collaborates with global clinics, reporting "astonishing" successes in extending life without the ravages of chemotherapy or radiation. Yet, he laments the oncogenic paradox: diverse triggers converge on mitochondrial failure, but standard treatments exacerbate it by flooding tumors with fermentable fuels. In glioblastoma cases, radiation and temozolomide liberate glucose and glutamine, sealing fates—patients survive mere months longer despite a century of stagnation. "The human brain should rarely if ever be irradiated," Seyfried warns, highlighting how these interventions sign death certificates.

The professor critiques a healthcare system beholden to profit, where metabolic approaches lack business models despite preclinical triumphs. Drugs like 6-diazo-5-oxo-L-norleucine (DON), once used in children, are withheld for human cancer trials due to no revenue potential, even as they synergize with ketosis to triple drug delivery and curb toxicity. Seyfried points to survivors like Pablo Kelly, an eight-year glioblastoma outlier on a carnivore diet, whose tumor stabilized via low GKI—proof that patients can control destiny through self-monitoring. "You give the patient now power," he says, urging empowerment over helplessness.

Dietary mismatches fuel the epidemic: U.S. cancer rates tripled post-1977 low-fat guidelines, mirroring carb surges and chronic inflammation. Wild wolves and zoo primates evade cancer on natural fare, while domestic pets sicken on processed kibble—a stark indictment of Big Food's alliance with Big Pharma. Seyfried's Press-Pulse strategy applies sustained dietary pressure with pulsed, low-cost drugs, resolving not just tumors but comorbidities like diabetes. In mouse models, metastatic survival extends fivefold without sickness, a blueprint for humans if systemic barriers fall.

Resistance persists through institutional mandates requiring failed standards first, but patient advocacy offers hope. Seyfried envisions a brighter future: metabolic management extends quality life, potentially averting pediatric tragedies where radiation stunts minds. "The future of cancer is bright not bleak," he concludes, calling for education to spark a paradigm shift. As global deaths mount—1,600 daily in the U.S., 8,100 in China—his message demands dissemination: cancer is manageable, not a death sentence, if we target its metabolic heart.

Regardez moins, lisez plus avec

🔴Top Cancer Expert: This Is The WORST Food To Feed Cancer!